1 |
Kim HM, Shin HY, Lim KH, Ryu ST, Shin TY, ChaeHJ, Kim HR, Lyu YS, An NH, Lim KS. 2000. Taraxacum officinale inhibits tumor necrosis factor-alpha production from rat astrocytes. Immunopharmacol Immunotoxicol 22:519-530.
DOI
|
2 |
Hagymasi K, Blazovics A, Feher J, Lugasi A, Kristo ST,Kery A. 2000. The in vitro effect of dandelions antioxidants on microsomal lipid peroxidation. Phytother Res 14:43-44.
DOI
ScienceOn
|
3 |
Koo HN, Hong SH, Song BK, Kim CH, Yoo YH, KimHM. 2004. Taraxacum officinale induces cytotoxicity through TNF-alpha and IL-1alpha secretion in Hep G2 cells. Life Sci 74: 1149-1157.
DOI
ScienceOn
|
4 |
Hu C, Kitts DD. 2004. Luteolin and luteolin-7-O-glucoside from dandelion flower suppress iNOS and COX-2 in RAW264.7 cells. Mol Cell Biochem 265: 107-113.
DOI
ScienceOn
|
5 |
Schultz K, Carle R, Schieber A. 2006. Taraxacum-a review on its phytochemical and pharmacological profile. J Ethnopharmacol 107: 313-323.
DOI
ScienceOn
|
6 |
Sevanian A, Ursini F. 2000. Lipid peroxidation in membranes and low-density lipoproteins: similarities and differences.Free Radic Biol Med 29: 306-311.
DOI
ScienceOn
|
7 |
Stevenson LM, Matthias A, Banbury L, Penman KG, Bone KM, Leach DL, Lehmann RP. 2005. Modulation of macrophage immune responses by Echinacea. Molecule 10:1279-1285.
DOI
ScienceOn
|
8 |
D'Agostino P, Ferlazzo V, Milano S, La Rosa M, Di BellaG, Caruso R, Barbera C, Grimaudo S, Tolomeo M, FeoS, Cillari E. 2001. Anti-inflammatory effects of chemically modified tetracyclines by the inhibition of nitric oxide and interleukin-12 synthesis in J774 cell line. Int Immunopharmacol 1: 1765-1776.
DOI
ScienceOn
|
9 |
Fautz RB, Husein B, Hechenberger C. 1991. Application of the neutral red assay (NR assay) to monolayer cultures of primary hepatocytes: rapid colorimetric viability determination for the unscheduled DNA synthesis test (UDS).Mutat Res 253: 173-179.
DOI
ScienceOn
|
10 |
Fraga CG, Leibovitz BE, Tappel AL. 1988. Lipid peroxidation measured as thiobarbituric acid-reactive substances in tissue slices: characterization and comparison with homogenates and microsomes. Free Radic Biol Med 4: 155-161.
DOI
ScienceOn
|
11 |
Kolb H, Kolb-Bachofen V. 1992. Nitric oxide: a pathogenetic factor in autoimmunity. Immunol Today 13: 157-160.
DOI
ScienceOn
|
12 |
Berliner JA, Navab M, Fogelman AM, Frank JS, DemerLL, Edwards PA, Watson AD, Lusis AJ. 1995. Atherosclerosis:basic mechanisms. Oxidation, inflammation, and genetics. Circulation 91: 2488-2496.
DOI
ScienceOn
|
13 |
Gobert AP, Mersey BD, Cheng Y, Blumberg DR, NewtonJC, Wilson KT. 2002. Cutting edge: urease release by Helicobacter pylori stimulates macrophage inducible nitric oxide synthase. J Immunol 168: 6002-6006.
DOI
|
14 |
van Acker SA, van den Berg DJ, Tromp MN, GriffioenDH, van Bennekom WP, van der Vijgh WJ, Bast A. 1996.Structural aspects of antioxidant activity of flavonoids. Free Radic Biol Med 20: 331-342.
DOI
ScienceOn
|
15 |
Noguchi N, Niki E. 2000. Phenolic antioxidants: a rationale for design and evaluation of novel antioxidant drug for atherosclerosis. Free Radic Biol Med 28: 1538-1546.
DOI
ScienceOn
|
16 |
Rathmell JC, Thompson CB. 1999. The central effectors of cell death in the immune system. Annu Rev Immunol17: 781-828.
DOI
ScienceOn
|
17 |
Tracey KJ, Cerami A. 1994. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med 45:491-503.
DOI
ScienceOn
|
18 |
Akira S, Taga T, Kishimoto T. 1993. Interleukin-6 in biology and medicine. Adv Immunol 54: 1-78.
DOI
|
19 |
Nathan C, Xie QW. 1994. Regulation of biosynthesis of nitric oxide. J Biol Chem 269: 13725-13728.
|
20 |
Dargel R. 1992. Lipid peroxidation--a common pathogenetic mechanism?. Exp Toxicol Pathol 44: 169-181.
DOI
ScienceOn
|
21 |
Bisset NG, Wichtl M. 1994. Herbal drugs and phytopharmaceuticals:a handbook for practice on a scientific basis. 2nd ed. CRC Press, New York, USA.
|
22 |
Newall CA, Anderson LA, Phillipson JD. 1996. Herbal medicines: a guide for health-care professionals. Pharmaceutical Press, London, UK.
|
23 |
Racz-Kotilla E, Racz G, Solomon A. 1974. The action of Taraxacum officinale extracts on the body weight and diuresis of laboratory animals. Planta Med 26: 212-217.
DOI
|
24 |
Williams CA, Goldstone F, Greenham J. 1996. Flavonoids, cinnamic acids and coumarins from the different tissues and medicinal preparations of Taraxacum officinale. Phytochemistry 42: 121-127.
DOI
ScienceOn
|
25 |
Doll R. 1990. An overview of the epidemiological evidence linking diet and cancer. Proc Nutr Soc 49: 119-131.
DOI
ScienceOn
|
26 |
Harris GK, Qian Y, Leonard SS, Sbarra DC, Shi X. 2006.Luteolin and chrysin differentially inhibit cyclooxygenase-2 expression and scavenge reactive oxygen species but similarly inhibit prostaglandin-E2 formation in RAW 264.7 cells. J Nutr 136: 1517-1521.
DOI
|
27 |
Hertog MG, Sweetnam PM, Fehily AM, Elwood PC,Kromhout D. 1997. Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. Am J Clin Nutr 65: 1489-1494.
DOI
|
28 |
Knekt P, Jarvinen R, Reunanen A, Maatela J. 1996. Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ 312: 478-481.
DOI
ScienceOn
|